Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
HRA Pharma
All potential subject coming to a site looking to purchase EC will be offered to participate in the study. Subjects who meet the initial screening inclusion criteria for the study will review package information and make a self-selection and purchase decision. Subjects who meet all remaining inclusion criteria will purchase ella®, and use based on their understanding of the package information.
Follow-up data regarding product use and adverse events will be obtained during telephone interviews at approximately Week-2 and Week-6 after the date the subject was dispensed study product.
Age
Any age
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Women who are self-pay or who are willing to be self-pay for the purposes of the study and who present for emergency contraception only for their own use
You may not be if
Cannot read, speak and understand English
Cannot see well enough to read information on the label
Clareo Health | A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
